These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20047144)

  • 21. The expanding TOR signaling network.
    Martin DE; Hall MN
    Curr Opin Cell Biol; 2005 Apr; 17(2):158-66. PubMed ID: 15780592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension.
    Mejias M; Garcia-Pras E; Gallego J; Mendez R; Bosch J; Fernandez M
    J Hepatol; 2010 Apr; 52(4):529-39. PubMed ID: 20206401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinase.
    Du M; Shen QW; Zhu MJ; Ford SP
    J Anim Sci; 2007 Apr; 85(4):919-27. PubMed ID: 17178807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
    Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron deficiency down-regulates the Akt/TSC1-TSC2/mammalian Target of Rapamycin signaling pathway in rats and in COS-1 cells.
    Ndong M; Kazami M; Suzuki T; Uehara M; Katsumata S; Inoue H; Kobayashi K; Tadokoro T; Suzuki K; Yamamoto Y
    Nutr Res; 2009 Sep; 29(9):640-7. PubMed ID: 19854379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of the mammalian target of rapamycin signaling pathway in hepatocellular carcinoma.
    Subbiah IM; Brown RE; Fallon MB
    Hepatology; 2010 Oct; 52(4):1524. PubMed ID: 20680964
    [No Abstract]   [Full Text] [Related]  

  • 27. Herding Hippos: regulating growth in flies and man.
    Badouel C; Garg A; McNeill H
    Curr Opin Cell Biol; 2009 Dec; 21(6):837-43. PubMed ID: 19846288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sirolimus inhibits human pancreatic carcinoma cell proliferation by a mechanism linked to the targeting of mTOR/HIF-1 alpha/VEGF signaling.
    Wang Y; Zhao Q; Ma S; Yang F; Gong Y; Ke C
    IUBMB Life; 2007 Nov; 59(11):717-21. PubMed ID: 17968710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation and role of autophagy in mammalian cells.
    Meijer AJ; Codogno P
    Int J Biochem Cell Biol; 2004 Dec; 36(12):2445-62. PubMed ID: 15325584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. mTOR signaling, function, novel inhibitors, and therapeutic targets.
    Watanabe R; Wei L; Huang J
    J Nucl Med; 2011 Apr; 52(4):497-500. PubMed ID: 21421716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring mammalian target of rapamycin (mTOR) activity.
    Ikenoue T; Hong S; Inoki K
    Methods Enzymol; 2009; 452():165-80. PubMed ID: 19200882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 4-Substituted-7-azaindoles bearing a ureidobenzofuranone moiety as potent and selective, ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR).
    Tsou HR; MacEwan G; Birnberg G; Zhang N; Brooijmans N; Toral-Barza L; Hollander I; Ayral-Kaloustian S; Yu K
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2259-63. PubMed ID: 20188551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Targeting of the AKT-mTOR pathway in head and neck and lung cancer].
    Vignot S; Haberer S; Besse B
    Bull Cancer; 2009; 96 Suppl 1():S57-63. PubMed ID: 19433374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Handicapping the race to develop inhibitors of the phosphoinositide 3-kinase/Akt/mammalian target of rapamycin pathway.
    Granville CA; Memmott RM; Gills JJ; Dennis PA
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):679-89. PubMed ID: 16467077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck.
    Amornphimoltham P; Patel V; Sodhi A; Nikitakis NG; Sauk JJ; Sausville EA; Molinolo AA; Gutkind JS
    Cancer Res; 2005 Nov; 65(21):9953-61. PubMed ID: 16267020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor-1 (IGF-1) and leucine activate pig myogenic satellite cells through mammalian target of rapamycin (mTOR) pathway.
    Han B; Tong J; Zhu MJ; Ma C; Du M
    Mol Reprod Dev; 2008 May; 75(5):810-7. PubMed ID: 18033679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
    Fang CX; Yang X; Sreejayan N; Ren J
    Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissecting the role of mTOR: lessons from mTOR inhibitors.
    Dowling RJ; Topisirovic I; Fonseca BD; Sonenberg N
    Biochim Biophys Acta; 2010 Mar; 1804(3):433-9. PubMed ID: 20005306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of insulin, adipocyte hormones, and nutrient-sensing pathways in regulating fuel metabolism and energy homeostasis: a nutritional perspective of diabetes, obesity, and cancer.
    Marshall S
    Sci STKE; 2006 Aug; 2006(346):re7. PubMed ID: 16885148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in the protein kinase B signaling pathway.
    Woodgett JR
    Curr Opin Cell Biol; 2005 Apr; 17(2):150-7. PubMed ID: 15780591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.